Skip to main content
Top
Published in: Pediatric Nephrology 12/2015

01-12-2015 | Original Article

Elevated uric acid and obesity-related cardiovascular disease risk factors among hypertensive youth

Authors: Lauren D. Reschke, Edgar R. Miller III, Jeffrey J. Fadrowski, Lauren F. Loeffler, Kathryn W. Holmes, Lawrence J. Appel, Tammy M. Brady

Published in: Pediatric Nephrology | Issue 12/2015

Login to get access

Abstract

Background

Uric acid (UA) is associated with high blood pressure in adolescents and with left ventricular hypertrophy (LVH) and cardiovascular disease (CVD) in adults. We sought to determine if UA is independently associated with CVD risk factors and left ventricular mass (LVM) over time in hypertensive youth.

Methods

This was a 1-year prospective observational study of hypertensive children aged 3–19 years. Cross-sectional and longitudinal associations of serum UA with CVD risk factors and LVM were explored.

Results

Of the 49 children who completed both the baseline and 12-month assessments, at baseline the mean age was 13.8 years and mean UA was 5.5 mg/dL; 24 % had elevated UA, 51 % were overweight/obese and 39 % had LVH. Measures of adiposity, low high-density lipoprotein cholesterol, high-sensitivity C-reactive protein, LVM and LVH were all significantly associated with elevated UA at baseline, but not with change over time. Each 1 mg/dL increase in baseline UA was associated with a 2.5 g/m2.7 increase in the LVM index at follow-up (95 % confidence interval 0.64, 4.39; p = 0.01); after adjustment for age, sex, race, body mass index z-score, change in UA, time, blood pressure and medication use, this association was no longer significant.

Conclusions

Hypertensive children with elevated UA have a higher prevalence of obesity-related CVD risk factors. Among hypertensive children, UA may be a marker of adiposity and not an independent CVD risk factor.
Literature
2.
go back to reference Weintraub WS, Daniels SR, Burke LE, Franklin BA, Goff DC Jr, Hayman LL, Lloyd-Jones D, Pandey DK, Sanchez EJ, Schram AP, Whitsel LP, American Heart Association Advocacy Coordinating Committee, Council on Cardiovascular Disease in the Young, Council on the Kidney in Cardiovascular Disease, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Clinical Cardiology, and Stroke Council (2011) Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation 124:967–990CrossRefPubMed Weintraub WS, Daniels SR, Burke LE, Franklin BA, Goff DC Jr, Hayman LL, Lloyd-Jones D, Pandey DK, Sanchez EJ, Schram AP, Whitsel LP, American Heart Association Advocacy Coordinating Committee, Council on Cardiovascular Disease in the Young, Council on the Kidney in Cardiovascular Disease, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Clinical Cardiology, and Stroke Council (2011) Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation 124:967–990CrossRefPubMed
3.
4.
go back to reference Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey. JAMA 283:2404–2410CrossRefPubMed Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey. JAMA 283:2404–2410CrossRefPubMed
5.
go back to reference Niskanen LK, Laaksonen DE, Nyyssönen K, Alfthan G, Lakka HM, Lakka TA, Salonen JT (2004) Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 164:1546–1551CrossRefPubMed Niskanen LK, Laaksonen DE, Nyyssönen K, Alfthan G, Lakka HM, Lakka TA, Salonen JT (2004) Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 164:1546–1551CrossRefPubMed
6.
go back to reference Iwashima Y, Horio T, Kamide K, Rakugi H, Ogihara T, Kawano Y (2006) Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension. Hypertension 47:195–202CrossRefPubMed Iwashima Y, Horio T, Kamide K, Rakugi H, Ogihara T, Kawano Y (2006) Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension. Hypertension 47:195–202CrossRefPubMed
7.
go back to reference Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ (2013) The role of uric acid in the pathogenesis of human cardiovascular disease. Heart 99:759–766CrossRefPubMed Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ (2013) The role of uric acid in the pathogenesis of human cardiovascular disease. Heart 99:759–766CrossRefPubMed
9.
go back to reference Mitsuhashi H, Yatsuya H, Matsushita K, Zhang H, Otsuka R, Muramatsu T, Takefuji S, Hotta Y, Kondo T, Murohara T, Toyoshima H, Tamakoshi K (2009) Uric acid and left ventricular hypertrophy in Japanese men. Circ J 73:667–672CrossRefPubMed Mitsuhashi H, Yatsuya H, Matsushita K, Zhang H, Otsuka R, Muramatsu T, Takefuji S, Hotta Y, Kondo T, Murohara T, Toyoshima H, Tamakoshi K (2009) Uric acid and left ventricular hypertrophy in Japanese men. Circ J 73:667–672CrossRefPubMed
10.
go back to reference Krishnan E, Hariri A, Dabbous O, Pandya BJ (2012) Hyperuricemia and the echocardiographic measures of myocardial dysfunction. Congest Heart Fail 18:138–143CrossRefPubMed Krishnan E, Hariri A, Dabbous O, Pandya BJ (2012) Hyperuricemia and the echocardiographic measures of myocardial dysfunction. Congest Heart Fail 18:138–143CrossRefPubMed
11.
go back to reference Feig DI, Soletsky B, Johnson RJ (2008) Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 300:924–932PubMedCentralCrossRefPubMed Feig DI, Soletsky B, Johnson RJ (2008) Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 300:924–932PubMedCentralCrossRefPubMed
15.
go back to reference Fernandez JR, Redden DT, Pietrobelli A, Allison DB (2004) Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 145:439–444CrossRefPubMed Fernandez JR, Redden DT, Pietrobelli A, Allison DB (2004) Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 145:439–444CrossRefPubMed
16.
go back to reference Urbina E, Alpert B, Flynn J, Hayman L, Harshfield GA, Jacobson M, Mahoney L, McCrindle B, Mietus-Snyder M, Steinberger J, Daniels S, American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee (2008) Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American heart association atherosclerosis, hypertension, and obesity in youth committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension 52:433–451CrossRefPubMed Urbina E, Alpert B, Flynn J, Hayman L, Harshfield GA, Jacobson M, Mahoney L, McCrindle B, Mietus-Snyder M, Steinberger J, Daniels S, American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee (2008) Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American heart association atherosclerosis, hypertension, and obesity in youth committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension 52:433–451CrossRefPubMed
17.
go back to reference National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576, 2 Suppl 4th report National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576, 2 Suppl 4th report
18.
go back to reference Tschudy MM, Arcara KM (eds) (2012) The Harriet Lane handbook a manual for pediatric house officers, 19th edn. Elsevier Mosby, Philadelphia, p 647 Tschudy MM, Arcara KM (eds) (2012) The Harriet Lane handbook a manual for pediatric house officers, 19th edn. Elsevier Mosby, Philadelphia, p 647
19.
go back to reference Shatat IF, Abdallah RT, Sas DJ, Hailpern SM (2012) Serum uric acid in U.S. adolescents: distribution and relationship to demographic characteristics and cardiovascular risk factors. Pediatr Res 72:95–100CrossRefPubMed Shatat IF, Abdallah RT, Sas DJ, Hailpern SM (2012) Serum uric acid in U.S. adolescents: distribution and relationship to demographic characteristics and cardiovascular risk factors. Pediatr Res 72:95–100CrossRefPubMed
20.
go back to reference Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458 Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458
21.
go back to reference Khoury PR, Mitsnefes M, Daniels SR, Kimball TR (2009) Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr 22:709–714CrossRefPubMed Khoury PR, Mitsnefes M, Daniels SR, Kimball TR (2009) Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr 22:709–714CrossRefPubMed
23.
go back to reference Greenland S, Finkle WD (1995) A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol 142:1255–1264PubMed Greenland S, Finkle WD (1995) A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol 142:1255–1264PubMed
24.
go back to reference Grayson PC, Kim SY, LaValley M, Choi HK (2011) Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 63:102–110CrossRef Grayson PC, Kim SY, LaValley M, Choi HK (2011) Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 63:102–110CrossRef
25.
go back to reference Feig DI (2012) The role of uric acid in the pathogenesis of hypertension in the young. J Clin Hypertens (Greenwich) 14:346–352CrossRef Feig DI (2012) The role of uric acid in the pathogenesis of hypertension in the young. J Clin Hypertens (Greenwich) 14:346–352CrossRef
26.
go back to reference Loeffler LF, Navas-Acien A, Brady TM, Miller ER 3rd, Fadrowski JJ (2012) Uric acid level and elevated blood pressure in US adolescents: national health and nutrition examination survey, 1999–2006. Hypertension 59:811–817PubMedCentralCrossRefPubMed Loeffler LF, Navas-Acien A, Brady TM, Miller ER 3rd, Fadrowski JJ (2012) Uric acid level and elevated blood pressure in US adolescents: national health and nutrition examination survey, 1999–2006. Hypertension 59:811–817PubMedCentralCrossRefPubMed
28.
go back to reference Yang Q, Zhang Z, Kuklina EV, Fang J, Ayala C, Hong Y, Loustalot F, Dai S, Gunn JP, Tian N, Cogswell ME, Merritt R (2012) Sodium intake and blood pressure among US children and adolescents. Pediatrics 130:611–619CrossRefPubMed Yang Q, Zhang Z, Kuklina EV, Fang J, Ayala C, Hong Y, Loustalot F, Dai S, Gunn JP, Tian N, Cogswell ME, Merritt R (2012) Sodium intake and blood pressure among US children and adolescents. Pediatrics 130:611–619CrossRefPubMed
29.
go back to reference Forman JP, Scheven L, de Jong PE, Bakker SJ, Curhan GC, Gansevoort RT (2012) Association between sodium intake and change in uric acid, urine albumin excretion, and the risk of developing hypertension. Circulation 125:3108–3116PubMedCentralCrossRefPubMed Forman JP, Scheven L, de Jong PE, Bakker SJ, Curhan GC, Gansevoort RT (2012) Association between sodium intake and change in uric acid, urine albumin excretion, and the risk of developing hypertension. Circulation 125:3108–3116PubMedCentralCrossRefPubMed
Metadata
Title
Elevated uric acid and obesity-related cardiovascular disease risk factors among hypertensive youth
Authors
Lauren D. Reschke
Edgar R. Miller III
Jeffrey J. Fadrowski
Lauren F. Loeffler
Kathryn W. Holmes
Lawrence J. Appel
Tammy M. Brady
Publication date
01-12-2015
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 12/2015
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-015-3154-y

Other articles of this Issue 12/2015

Pediatric Nephrology 12/2015 Go to the issue